The latest articles from BioStock
» Genovis' ace up his sleeve
» Dilafor begins collaboration with Liverpool University on SARS-CoV-2
» BrainCool receives multi-million euro support from the EU
» New study opens the door to precision medicine for Scandion Oncology
» World Hemophilia Day: Idogen works for patients who lack treatment
» Lipum strengthens the board with an experienced associate professor
Read BioStock's latest newsletter for week 16 here.
Johan Oak has been appointed as the new President and CEO of Handicare. Read more.
Last day to shop WntResearch including pre-emptive rights in the issue is today, April 20. Read more.
Today, trading begins with CELLINKs actier på Nasdaq Stockholm main market. Read more.
Bactiguard has informed about the 2020 Annual General Meeting and invited to the CEO presentation on April 28. Read more.
Vistin Pharma has invited you to a teleconference in connection with the interim report on April 23. Read more.
ObsteCare will present at ProHearings on April 24th. Read more.
Biotec Pharmacon has invited to the Q1 2020 results presentation on April 23. Read more.
Notices of general meetings:
Nicoccino UsDsign
Annual reports:
C-Row Inhalation Sciences Peptonic Medical
News received since last Friday:
CELLINKs The founder has informed about the exercise of a call option. Read more.
De Novo application has been submitted to FDA respect BONESUPPORTs CERAMENT G. Read more.
AcouBlack has been granted a patent for a new method of separating cells using sound. Read more.
Getinge has issued Covid-19 corporate certificates worth SEK 1 billion. Read more.
Linn Mandahl, CEO of Abbvie Scandinavia, has taken place in Medicon Valley Alliances board and Malmö University becomes a group member of the organization. Read more.
Contigo Care has postponed the Annual General Meeting to June 29. Read more.
Changes have been made to the arrangements around AstraZeneca the annual general meeting. Read more.
Share transactions have been announced in Orphazyme of people leaving management positions. Read more.
Oncology Venture has issued 925,925 shares in connection with the convertible agreement with Negma Group and Park Partners GP. Read more.
Penser Access has published an analysis of Surgical Science: “Changed guidance for largest customer”. Read more.
This morning's winner: Kancera 30,7%, Scandinavian Chemotech 26,7%, LifeAssays 25%, Xspray Pharma 17,2%, Attana 14,15%
This morning's losers: Euri -13,2%, Cereno Scientific -7,3%, PharmaLundensis -7,19%, Pharmacolog -6,5%, Mentice -6,5%
Index: OMXS30 1530 -0,28% Healthcare +1,54%
More articles from BioStock
» PHI's new operations manager looks beyond Corona
» Karolinska Development has sold parts of its holding in Aprea
» Alligator secures long-term development
» Cyxone's T20K can improve the quality of life for MS patients
» Immunicum's annual report highlights the company's competitive advantages